These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33748410)

  • 1. Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction.
    Kotecha S; Paul E; Ivulich S; Fuller J; Paraskeva M; Levvey B; Snell G; Westall G
    Transplant Direct; 2021 Apr; 7(4):e681. PubMed ID: 33748410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithymocyte Globulin Treatment for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Experience From a National Reference Transplant Center.
    Margallo Iribarnegaray J; De Pablo Gafas A; Alonso Moralejo R; Quezada Loaiza CA; Revuelta Salgado F; Pina Maíquez I; Pérez González VL
    Transplant Proc; 2021 Nov; 53(9):2710-2717. PubMed ID: 34593251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit Antithymocyte Globulin for Treatment of Corticosteroid Refractory Acute Cellular Rejection After Lung Transplantation.
    Rudzik KN; Moore CA; Sacha LM; Rivosecchi RM; Saul M; Pilewski JM; Kilaru SD; Snyder ME; McDyer JF; Iasella CJ
    Transplantation; 2023 Aug; 107(8):1828-1834. PubMed ID: 37143198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
    Vazirani J; Routledge D; Snell GI; Watson D; Paraskeva M; Westall GP; Harrison SJ
    Transplant Proc; 2021; 53(1):296-302. PubMed ID: 33039145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast in chronic lung allograft dysfunction after lung transplantation.
    Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
    J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
    Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
    Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.
    Van Herck A; Frick AE; Schaevers V; Vranckx A; Verbeken EK; Vanaudenaerde BM; Sacreas A; Heigl T; Neyrinck AP; Van Raemdonck D; Dupont LJ; Yserbyt J; Verleden SE; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Mar; 38(3):252-259. PubMed ID: 30686699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Rabbit Antithymocyte Globulin in Chronic Lung Allograft Dysfunction.
    Izhakian S; Wasser WG; Fox BD; Vainshelboim B; Reznik JE; Kramer MR
    Transplant Proc; 2016; 48(6):2152-6. PubMed ID: 27569962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.
    Benazzo A; Schwarz S; Muckenhuber M; Schweiger T; Muraközy G; Moser B; Sigüenza JM; Lang G; Taghavi S; Klepetko W; Hoetzenecker K; Jaksch P; Lambers C
    PLoS One; 2019; 14(1):e0210443. PubMed ID: 30645645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction.
    January SE; Fester KA; Bain KB; Kulkarni HS; Witt CA; Byers DE; Alexander-Brett J; Trulock EP; Hachem RR
    Clin Transplant; 2019 Oct; 33(10):e13708. PubMed ID: 31494969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Rationale of a Scandinavian Multicenter Randomized Study Evaluating if Once-Daily Tacrolimus Versus Twice-Daily Cyclosporine Reduces the 3-year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation (ScanCLAD Study).
    Dellgren G; Lund TK; Raivio P; Leuckfeld I; Svahn J; Magnusson J; Riise GC
    Adv Ther; 2020 Mar; 37(3):1260-1275. PubMed ID: 31993943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
    Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
    PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Retransplantation for Chronic Rejection: A Single-Center Experience.
    Biswas Roy S; Panchanathan R; Walia R; Varsch KE; Kang P; Huang J; Hashimi AS; Mohanakumar T; Bremner RM; Smith MA
    Ann Thorac Surg; 2018 Jan; 105(1):221-227. PubMed ID: 29100649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection, classification, and management of rejection after lung transplantation.
    Parulekar AD; Kao CC
    J Thorac Dis; 2019 Sep; 11(Suppl 14):S1732-S1739. PubMed ID: 31632750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
    Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
    Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 20. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
    Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
    Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.